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ABSTRACT:  
Background: CMRA in pediatrics remains challenging due to the smaller vessel size, high 
heart rates (HR), potential image degradation caused by limited patient cooperation and long 
acquisition times. High-relaxivity contrast agents have been shown to improve coronary 
imaging in adults, but limited data is available in children. We sought to investigate whether 
gadobenate dimeglumine (Gd-BOPTA) together with self-navigated inversion-prepared 
coronary magnetic resonance angiography (CMRA) sequence design improves coronary 
image quality in pediatric patients. 
Methods: Forty consecutive patients (mean age 6±2.8 years; 73% males) were prospectively 
recruited for a 1.5-T MRI study under general anesthesia. Two electrocardiographic-triggered 
free breathing steady-state free precession (SSFP) angiography sequences (A and B) with 
isotropic spatial resolution (1.3mm
3
) were acquired using a recently developed image-based 
self-navigation technique. Sequence A was acquired prior to contrast administration using T2 
magnetization preparation (T2prep). Sequence B was acquired 5-8minutes after a bolus of 
Gd-BOPTA with the T2prep replaced by an inversion recovery (IR) pulse to null the signal 
from the myocardium. Scan time, signal-to noise and contrast-to-noise ratios (SNR and 
CNR), vessel wall sharpness (VWS) and qualitative visual score for each sequence were 
compared. 
Results: Scan time was similar for both sequences (5.3±1.8 vs 5.2±1.5 minutes, p=0.532) and 
average heart rate (78±14.7 vs 78±14.5 bpm, p=0.443) remained constant throughout both 
acquisitions. Sequence B resulted in higher SNR (12.6±4.4 vs 31.1±7.4, p<0.001) and CNR 
(9.0±1.8 vs 13.5±3.7, p<0.001) and provided improved coronary visualization in all coronary 
territories (VWS A=0.53±0.07 vs B=0.56±0.07, p=0.001; and visual scoring A=3.8±0.59 vs 
B=4.1±0.53, p<0.001). The number of non-diagnostic coronary segments was lower for 
sequence B [A=42 (13.1%) segments vs B=33 (10.3%) segments; p=0.002], and contrary to 
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the pre-contrast sequence, never involved a proximal segment. These results were 
independent of the patients’ age, body surface area and HR.  
Conclusions: The use of Gd-BOPTA with a 3D IR SSFP CMRA sequence results in 
improved coronary visualization in small infants and young children with high HR within a 
clinically acceptable scan time. 
 
Key words: Gadobenate dimeglumine; respiratory image-based navigation; coronary 
magnetic resonance angiography; pediatric congenital heart disease. 
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Abbreviations list:
 
BP-CA – blood pool contrast agent 
BSA – body surface area 
SSFP – steady state free precession 
CHD – congenital heart disease 
CMR – cardiovascular magnetic resonance 
CMRA – coronary magnetic resonance 
angiography 
CNR – contrast-to-noise ratio 
CoA – aortic coarctation 
EC-GBCA – extra-cellular gadolinium-based 
contrast agent 
ECG – electrocardiogram 
Gd-BOPTA – gadobenate dimeglumine 
HR – heart rate 
iNAV – image-based navigator 
IR – inversion recovery 
LAD – left anterior descending artery 
LCx – left circumflex artery 
MRI – magnetic resonance imaging 
RCA – right coronary artery 
SNR – signal-to-noise ratio 
VWS – vessel wall sharpness 
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INTRODUCTION 
Three-dimensional (3D) whole-heart coronary magnetic resonance angiography 
(CMRA) is a well-established technique to assess cardiovascular morphology and coronary 
anatomy in patients with congenital heart disease (CHD) (1-3). The ability of CMRA to 
reliably identify the origin and proximal course of the coronary arteries and the desire to 
minimize radiation exposure makes this an ideal modality to image infants and young 
children with suspected coronary anomalies. 
CMRA is typically acquired during free breathing using an electrocardiographic 
(ECG) triggered steady-state free-precession (SSFP) readout and T2-preparation pulses to 
generate contrast between blood and myocardium. It is frequently combined with a fat-
suppression technique to eliminate the signal from epicardial and mediastinal fat (3). 
Conventionally, a respiratory navigator positioned on the diaphragm has been used to 
suppress respiratory motion artifacts by only accepting data acquired in a predefined 
respiratory gating window (4). More recently, improved respiratory motion compensation has 
been achieved using 1D or image-based self-navigation, whereby motion is measured directly 
on the heart. This has been shown to out-perform the conventional respiratory motion 
compensation approach and to improve image quality (5-7).  
Although in most adult cases the origin and proximal course of the coronary arteries 
can be visualized by non-contrast enhanced CMRA, coronary imaging in pediatrics remains 
challenging and the experience is still limited (1,2,8). In fact, despite ongoing advances in 
CMRA sequence development and post-processing techniques, a number of factors can result 
in lengthy and suboptimal imaging acquisitions: high heart rates (HR) therefore shorter rest 
periods (shorter diastasis, where cardiac motion is minimal and acquisition window is ideal 
for coronary imaging); irregular breathing (thus low respiratory tracking efficiency); small 
diameter of the coronary arteries; and poor contrast between the blood pool and extravascular 
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structures (e.g. pericardial fluid). Such acquisitions are prone to respiratory and cardiac 
motion artifacts. In recent years, respiratory image-based navigator (iNAV) techniques have 
been shown to improve image quality compared to conventional motion compensation, in 
patients with congenital heart disease. A further challenge of pediatric CMRA is that most 
images have relative lower spatial-resolution and signal-to-noise ratio (SNR) in comparison 
with their adult counterparts, thus reducing diagnostic accuracy. Finally, in many cases 
contrast-agents are given to assess myocardial perfusion and viability, which increases the 
SNR of SSFP sequences and thus improves image quality of CMRA (9-11). 
Improved contrast may be achieved by replacing the T2 preparation pulses with an 
inversion-recovery (IR) pulse. This introduces heavy T1-weighting and thus is beneficial with 
the administration of a T1-shortening contrast-agent (12,13). In addition, signal from 
pericardial fluid (typically bright on T2-prepared CMRA) can be suppressed due to its long 
T1.  In some subjects, high signal from fluid within the pericardial recesses with T2-prepared 
approaches can obscure the proximal coronary arteries.  
Gd-BOPTA is a second-generation contrast agent. It has higher relaxivity compared 
to non-specific Gd-chelates due to binding to blood albumin, also called receptor induced 
magnetization enhancement (RIME) and consequently slower total blood clearance and 
longer plasma half-life, resulting in a higher and prolonged intravascular signal. The use of 
high-relaxivity contrast-agents has been shown to improve coronary imaging in adult 
patients, but limited data is available in pediatric patients (11,12,14,15). 
The purpose of this study was to compare the use of a high-relaxivity contrast-agent, 
gadobenate dimeglumine (Gd-BOPTA, MultiHance; Bracco Imaging, Milan, Italy) in 
combination with specific sequence design to conventional T2-prepared 3D-SSFP CMRA in 
pediatric patients with CHD.   
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METHODS 
Study population 
The study was approved by the local institutional research ethics committee (South 
East London Research Ethic Committee, 10/H0802/65). Informed consent was obtained from 
all participants’ parents/guardians prior to scanning. The inclusion criterion was children (age 
>2 years) with CHD with a clinically indicated cardiovascular magnetic resonance (CMR) 
study requiring general anesthesia referred to our Department. Exclusion criteria included any 
contra-indications to MRI (e.g. pacemakers), known allergy to MRI contrast-agents and 
impaired renal function. 
Forty consecutive children over 2 years old were prospectively enrolled (September 
2013 to February 2015). All scans were performed on a 1.5-T clinical scanner (Achieva, 
Philips Healthcare, Best, The Netherlands). All examinations were done under general 
anesthesia, following the local institutional practice for infants and small children and after 
careful weighting the benefits of a diagnostic examination, the developmental maturity and 
prior patient’s experience, parents’ insights of their child’s capacity to cooperate with the 
study and the anticipated length of the CMR protocol. 
Coronary MRA Sequence 
The whole-heart CMRA scan consisted of an ECG-triggered 3D-SSFP sequence with 
the following imaging parameters: repetition time/echo time (TR/TE)=4.5/2.2ms; flip 
angle=70°; isotropic spatial resolution with an acquired voxel size of 1.3×1.3×1.3mm 
(0.65x0.65x0.65mm reconstructed voxel size); SENSE factor=2. Images were acquired using 
a 5-channel phased-array cardiac coil. 
The CMRA acquisition had a coronal orientation with readout in foot–head direction, 
phase encoding in left–right direction and slice encoding in anterior–posterior direction. The 
coronal orientation was chosen to exclude the chest wall and minimize respiratory motion 
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artifacts. Data acquisition was synchronized with the ECG to coincide with the longest 
quiescent cardiac phase. The optimal trigger delay time and acquisition window were 
determined from an axial high-temporal resolution four-chamber cine. Single-phase studies 
were acquired and the longest rest period of the heart coinciding with the late-systolic or 
diastolic-phase images was determined primarily by evaluating the movement of the right 
coronary artery (RCA) (16).  
The conventional pre-contrast coronary MRI sequence used a fat-suppression pre-
pulse and T2-preparation pre-pulse to suppress signal from the myocardium and improve the 
blood-to-myocardium contrast (sequence A). Subsequently, contrast (Gd-BOPTA) was 
administered as a bolus by hand injection followed by 10 to 20 milliliters (mL) of a saline 
bolus (11). The post-contrast CMRA scan (sequence B) was performed approximately 5-8 
minutes after the injection of Gd-BOPTA (0.2mL per kilogram of body-weight) following 
previous experience (9,17) and after a pre-study validation of the technique in five patients. 
This allowed the circulating contrast material to stabilize in the blood-pool and thereby avoid 
significant changes in the inversion-time during the post-contrast scanning. For the post-
contrast CMRA scan, an IR-approach was used to null signal from the myocardium. The 
optimal inversion-time for nulling the myocardium was determined using a Look-Locker 
sequence prior to the post-contrast CMRA.  
For respiratory motion compensation, both sequence A and B used a recently 
developed image-based navigator (iNAV) (18). In short, this method used the start-up echoes 
of the SSFP sequences to generate a low-resolution 2D projection image of the heart, with the 
same geometric properties as the whole-heart CMRA. The iNAV was then used to directly 
track and correct the respiratory motion of the heart in the foot-head and left-right directions. 
Additionally, respiratory gating with a constant efficiency of 50% was used to limit data 
acquisition to end-expiration. 
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The rest of the CMR protocol was dictated by the clinical indication and imaging 
findings, including conventional cine acquisitions in short and long-axis, phase-contrast flows 
and a time-resolved contrast-enhanced angiography with keyhole. 
Data analysis 
Quantitative analysis – Acquisition of a noise image required for global SNR and 
CNR calculations with parallel imaging was not considered practical due to time constraints 
(19). Nevertheless, by ensuring imaging parameters such as the patient position, field-of-
view, matrix-size, flip-angle, phase-encoding direction and acceleration factor were 
unchanged between sequence A and B, and by selecting identical regions-of-interest (ROIs) 
in both sets of resulting images, a local SNR (SNRl) and local CNR (CNRl) were calculated 
as detailed:  
𝑆𝑁𝑅𝑙 =
𝐼𝐵
𝑆𝐷 (𝐿)
 
𝐶𝑁𝑅𝑙 =
𝐼𝐵 − 𝐼𝑀
𝑆𝐷 (𝐿)
 
 
where IB and IM refers to the mean signal-intensity in an ROI in the blood-pool (proximal 
ascending aorta) and myocardium (mid ventricular septum) respectively, and SD (L) refers to 
the standard deviation of an ROI of air in the lungs (chosen to contain a minimum of 100 
pixels while avoiding any visible vascular structures). These ROIs were specifically drawn in 
similar locations in both sequence A and B (MSV, 5 years of experience in CMR and Society 
of Cardiovascular Magnetic Resonance level 3 training) by using patient-specific landmarks.  
Coronary reformatting and quantitative analysis of vessel length, diameter and wall 
sharpness was performed using a dedicated software ("Soap-Bubble”, Philips Medical 
Systems, Best, The Netherlands), as previously described (12,20). This custom-made 
validated tool facilitates multiplanar reformats of CMRA datasets, while also providing 
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vessel length and diameter for objective quantitative comparison (figure 1 supplementary 
material). Furthermore, the local vessel wall sharpness (VWS) can be obtained by means of a 
Deriche algorithm (20,21), which is the basis of a semiautomated vessel-tracking tool to 
identify the vessel borders along the path. In brief, by using a first-order derivative (edge) of 
the input image, the local magnitude change in signal intensity can be calculated, which then 
provides a single VWS value for the entire path (a higher percentage magnitude change at the 
edge is consistent with superior sharpness).  
Qualitative image analysis – Coronary image quality was determined on the basis of a 
5-point grading system (table 1), which has been previously described (12). Analysis was 
performed by two independent experienced readers (reader 1 - ND, 4 years of experience in 
CMR; reader 2 - VV, 4 years of experience in CMR and Society of Cardiovascular Magnetic 
Resonance level 3 training). Grading involved careful visual inspection of the image quality 
of the proximal to distal segments of the coronary arteries of each patient dataset, according 
to the standardized American Heart Association (AHA) coronary segmentation model 
adapted for cardiovascular computed tomography angiography (22). Both readers were 
blinded to the study results or details of the sequences used to report the findings. Prior to the 
study analysis, agreement was assessed on illustrative coronary imaging cases not part of the 
study sample (figure 2 supplementary material).  
Statistical Analysis  
A sample size calculation was performed prior to the study to plan recruitment. Using 
a standard deviation of 10% taken from previous VWS measurements in congenital CMRA 
(23), a power level of 80%, and a significance level of 0.05 to detect a clinically significant 
change of 10% in vessel sharpness, 36 patients were estimated to be needed for bivariate 
analysis. Quantitative variables are expressed as mean ± standard deviation (SD). Image 
quality and vessel length, diameter, and wall sharpness pre and post-contrast were compared 
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using the paired t test for parametric variables and with the Wilcoxon signed rank test for 
nonparametric variables. One-way ANOVA and Tukey HSD post hoc test were used to test 
for any difference in mean VWS values per coronary artery territory imaged with both pre 
and post-contrast sequences.  
Intra- and inter-observer variability for the qualitative scores given to each coronary 
segments imaged with sequences A and B was evaluated using the 95% limits-of-agreement 
approach proposed by Bland and Altman (24) and the Cohen’s kappa coefficient. This was 
performed for the 40 subjects enrolled and each independent reader was blinded to the details 
of the sequence used. For the intra-observer variability, each reader scored each coronary 
segment twice in different days to reduce any potential bias. For the inter-observer 
variability, the average qualitative score given to each coronary segment by one of the 
readers was compared to the results obtained by the other reader. The kappa coefficient of 
agreement was graded as follows: 0 to 0.2 = poor to slight; 0.21 to 0.4 = fair; 0.41 to 0.6 = 
moderate; 0.61 to 0.8 substantial; and 0.81 to 1.0 = nearly perfect (25). 
Bivariate analyses were performed to assess any correlation between imaging 
parameters (VWS and qualitative score) and age, body surface area (BSA) and HR. 
Additionally, a multivariate linear regression model was built to explore if any of the 
patient’s variables (age, BSA, and HR) predicted the coronary imaging results. Differences 
were considered statistically significant at a p value <0.05 (2-tailed). All statistical analyses 
were performed using SPSS version 22.0 (IBM SPSS Statistics, IBM Corporation, Armonk, 
New York). 
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RESULTS 
Forty consecutive patients (mean age 6±2.8years; 73% males) were prospectively 
recruited. This constituted a very heterogeneous population in terms of clinical indications for 
the CMR study (table 2), that span from simple cardiac defects (e.g. atrial septal defects) to 
more complex CHD, representative of real-world referrals to a congenital CMR center. 
Figure 1 provides some examples of the coronary imaging results achieved with the two 
sequences. No adverse events or any contrast reaction were registered during this study.  
Table 3 summarizes the coronary imaging parameters and attributes of the two 
sequences. Both sequence A (pre-contrast) and sequence B (post-contrast) had similar 
acquisition durations (A=5.3±1.8 vs B=5.2±1.5 minutes; p=0.532). Furthermore, there was no 
significant difference in the HR during both sequence acquisitions, with a mean HR of 
78±14.7 for sequence A vs 78±14.5 bpm for sequence B (p=0.443). The average inversion 
time of sequence B was 234 ± 14.6 ms [210 – 260 ms]. The mean vessel length was 5.2±1.8 
(A) vs 6.4±2.0 cm (B) (p<0.001) for a similar average vessel diameter of 2.2±0.2 (A) vs 
2.2±0.2mm (B) (p=0.922).  
Five patients had coronary anomalies (table 4). Table 5 depicts the average qualitative 
score given by the two readers. There was substantial intra-observer (reader 1: sequence A 
k=0.545, p<0.001 and sequence B k=0.782, p<0.001; reader 2: sequence A k=0.654, p<0.001 
and sequence B k=0.743, p<0.001) and inter-observer agreement (sequence A k=0.75, 
p<0.001; sequence B k=0.717, p<0.001) for the qualitative coronary scores given by the two 
independent readers (figures 3 and 4 supplementary material).  
CMRA after Gd-BOPTA administration and acquired with a self-navigated IR SSFP 
sequence (B) resulted in significantly higher SNR (A=12.6±4.4 vs B=31.1±7.4; p<0.001) and 
CNR (A=9.0±1.8 vs B=13.5±3.7; p<0.001) compared to the pre-contrast self-navigated T2-
prepared SSFP sequence (A).  
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Overall, higher coronary VWS (A=0.53±0.07 vs B=0.56±0.07; p=0.001) and 
qualitative scores (A=3.8±0.59 vs B=4.1±0.53; p<0.001) were achieved with sequence B as 
depicted in figures 2 and 3. Except for the left circumflex artery (LCx) VVS, this 
improvement was statistically significant in all coronary territories (table 5 and figure 3). The 
number of non-diagnostic coronary segments (score 1 and 2) was significantly lower for 
sequence B [A=42 (13.1%) vs B=33 (10.3%); p=0.002]. Furthermore, while there were three 
non-diagnostic proximal segments with sequence A (0.9%), all involving the LCx, there were 
none in the post-contrast sequence. In fact, it was in the LCx territory that both sequences had 
lower VWS and qualitative scores (table 5 and figure 3). However, when analyzing by 
coronary artery segment imaged, there were no statistically significant differences in the 
mean pre-contrast as well as in the mean post-contrast VWS as determined by one-way 
ANOVA (sequence A: F(2, 117)=0.651, p=0.524; sequence B: F(2, 117)=1.83, p=0.164). 
In our study, the same trigger delay was used for both sequence A and B and ranged 
from 180 to 290 milliseconds (msec) for systolic-triggered scans and 430 to 759 msec for 
diastolic acquisitions. Two thirds of the acquisitions (n=29; 72.5%) were synchronized with 
the diastolic phase. On bivariate analysis, there was no correlation between the resting trigger 
delay selected and the coronary VWS for both sequence A (R=0.071, p=0.663) and B 
(R=0.173, p=0.285). 
Finally, there was no correlation between patients’ variables such as age, BSA or HR 
and coronary VWS results as summarized in figure 5 scatterplots. None of these patient’s 
variables were shown to predict the coronary VWS values on the multiple linear regression 
analysis (R
2
=0.108, p=0.242 for sequence A; R
2
=0.033, p=0.744 for sequence B). 
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DISCUSSION 
In this prospective crossover trial, a sample of infants and young children with CHD 
referred to our center were imaged using two self-navigated SSFP sequences (A and B). In 
both we used a novel self-navigation approach (a fixed respiratory gating efficiency 50% was 
applied) based on a recently developed 2D iNAV (26). In contrast to a 1D diaphragmatic 
navigation approach (1D NAV), the new iNAV sequence used allows direct estimation and 
correction of the respiratory induced bulk cardiac motion and diaphragm-heart hysteresis. 
This can improved CMRA image quality and does not require any dedicated planning for the 
navigator setup, nor any additional post-processing steps (18,26).  More importantly, as 
gating efficiency for the iNAV sequence used was fixed at 50%, with the only the best 50% 
of the collected data used for image reconstruction, and all patients where scanned under 
general anesthesia (no change in the anesthetic procedure throughout the two experiments, 
with an average time interval between both of 18.05 ± 4.0 minutes), a head-to-head 
comparison of the two different CMRA acquisitions was possible. 
Therefore, the only difference between the two sequences investigated was the 
magnetization preparation scheme. Sequence B used an IR pre-pulse instead of a T2prep and 
was acquired 5-8 minutes after administration of Gd-BOPTA.  
Gd-BOPTA is a second-generation gadolinium contrast-agent, with a more lipophilic 
structure compared with conventional EC-GBCAs, which results in a weak and reversible 
interaction with serum albumin. This slows its extravasation out of the vascular space and 
increases its relaxivity compared to other agents, thus rendering a higher intravascular signal 
and improvement in diagnostic CMRA (11,15,27).  
The T1 shortening effects and prolonged intravascular time of Gd-BOPTA, together 
with the changed magnetization preparation scheme resulted in the higher SNR seen in the 
retention equilibrium-phase images of the post-contrast sequence (table 3). In fact, sequence 
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B was specifically designed to benefit from the prolonged intravascular half-life of Gd-
BOPTA and to increase the blood-to-background tissue contrast by means of an IR approach 
to null signal from the myocardium. This effect was also demonstrated by a significantly 
higher CNR. Because Gd-BOPTA resulted in a higher and stable intravascular signal, it also 
allowed isotropic high-spatial resolution imaging to be performed within a clinically feasible 
scan time of about five minutes, while also permitting dynamic vascular imaging with a 
single contrast injection (time-resolved angiography).  
Adding the contrast to the novel sequence design resulted in a significant 
improvement in coronary visualization independent of age, BSA and HR, known to have 
detrimental effects on image quality. This improvement was also noted in all coronary 
territories and it was in fact independent of the vessel imaged or the resting cardiac phase 
chosen.  
Notably, despite the fact that the mean vessel length obtained with sequence B was 
significantly higher than that of sequence A, both had similar mean vessel diameters. 
Although counterintuitive given the normal angiographic tapering of the coronary arteries, 
the post-contrast images had higher vascular signal and a better delineation of the wall, as 
demonstrated by a higher VWS. Because the vessel border was less clearly visualized before 
contrast injection, we hypothesize that signal loss due to partial volume artifact and noise 
resulted in underestimation of the true lumen in sequence A despite having the same spatial 
resolution as sequence B (28).  
If on the one hand the prolonged intravascular half-life and high T1 relaxivity of Gd-
BOPTA provides high homogenous signal that is not limited to the first-pass arterial-phase, 
on the other hand Gd-BOPTA can diffuse into the interstitial extracellular space due to its 
weak and reversible interaction with serum albumin and smaller molecules. However, this 
diffusion is slow, compared with EC-CAs (29), and so after setting the inversion time, the 
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myocardial signal remained nulled even after the 3D coronary imaging acquisition. 
Therefore, we hypothesize that the proposed sequence optimized for Gd-BOPTA may also 
enable tissue characterization with the same patient preparation as with EC-GBCAs and a 
single contrast bolus, with no need for dedicated or cumbersome mixed double contrast 
protocols (e.g. EC-GBCAs for perfusion/delayed enhancement followed by an intravascular 
agent for vascular imaging), a known limitation of “blood-pool” contrast agents (BP-CAs) 
imaging (10). Importantly, no heavy venous enhancement was seen with sequence B, which 
has been described to complicate interpretation of coronary imaging with BP-CAs (30). 
Coronary imaging in children is especially challenging due to their smaller size, small 
contrast bolus, relatively higher cardiac output and the potential for image degradation due to 
limited patient cooperation during the critical time window for image acquisition with EC-
GBCAs. The advent of high-relaxivity agents with prolonged intravascular transit can 
improve blood-background tissue differentiation thus facilitating visualization of the smaller 
coronary arteries, including the more distal branches. Gd-BOPTA has been shown to improve 
diagnostic coronary CMRA in adults, and its efficacy and safety profile makes it an appealing 
choice for coronary imaging in pediatric patients. Moreover, the use of Gd-BOPTA and the 
described sequence design is an attractive alternative to streamline CMR studies by enabling 
in a single examination detailed functional (ischemia/viability) and anatomical (coronary) 
assessment. The incremental diagnostic value of combined CA imaging, myocardial 
perfusion and late gadolinium enhancement using a versatile agent such as Gd-BOPTA has 
already been shown in adults (10). 
Limitations 
A number of limitations need to be acknowledged. First, although powered to identify 
any statistical significant difference between the two sequences, this was a single-center 
study performed in a center of expertise. Also, all scans were performed under general 
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anesthesia following the institutional practice and in the setting of a multidisciplinary clinical 
planning. This access to specialized personnel and equipment resources is not widely 
available and local practices vary. Nevertheless, general anesthesia ensured prolonged 
cooperation, reliable breathing pattern as well as less HR fluctuations. If on the one hand this 
might affect the transferability of the results to non-anesthetized pediatric studies, on the 
other hand this allowed an objective head-to-head comparison of two similarly defined 
sequences, whilst assessing for potential confounding factors such as HR changes/gating 
efficiency during the two different acquisitions (no differences in HR and acquisitions lengths 
were noted). We have previously demonstrated that the gating approach used improves 
coronary imaging in awake adult patients with CHD (18). We hypothesize that such 
improvement is likely to occur in awake pediatric scans but this remains to be proven. 
Notably, this protocol could also be adapted to other MRI vendors and help to streamline the 
imaging service delivery. 
In this study we have not assessed the diagnostic accuracy of the proposed sequence 
to screen for coronary stenosis/anomalies. On one hand, this was not a predefined study end-
point. On the other hand, there were not enough coronary anomalies in this study population 
to report on the accuracy of each sequence to be able to detect them. This would require a 
larger sample and, ideally, validation with invasive data, which without clinical justification 
was deemed unethical in a cohort of pediatric patients. However, we expect that the increase 
in spatial resolution attained with this high-relaxivity contrast agent and sequence design 
would help to reduce flow-induced signal voids, partial volume artifacts or velocity-shear 
effects. This would allow a more accurate diagnosis and estimation of the severity of a 
coronary stenosis, particularly in the proximal segments, as demonstrated previously (31,32).  
Finally, we have not tested the proposed protocol at higher field strength, which also 
has been shown to result in higher spatial resolution, SNR and CNR values between blood 
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and myocardium. However unreliable ECG-triggering due to amplified magneto-
hydrodynamic effects, frequent susceptibility artifacts, and increased T1 radiofrequency field 
distortions are known drawbacks.  
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CONCUSIONS 
The use of Gd-BOPTA with an IR 3D-SSFP sequence design that benefits of its 
attributes of high-relaxivity and prolonged intravascular time results in improved coronary 
imaging visualization in small infants and young children with high HR and within a 
clinically acceptable scan time. This approach may allow replacing invasive cardiac 
catheterization for diagnostic coronary imaging and preoperative planning in pediatrics thus 
reducing the risks associated with such procedures. 
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FIGURES LEGENDS 
 
Figure 1. CMRA reformatted images from six randomly selected patients with their 
demographic details, average HR, acquisition duration and image quality parameters 
depicting areas of improved visualization. Left-hand panels - sequence A (pre-contrast). 
Right-hand panels - sequence B (post-contrast). Arrows point to coronary segments with 
improved visualization after contrast. DORV, double outlet right ventricle; CoA, aortic 
coarctation; PAPVR, partial anomalous venous return; TGA, transposition of the great 
arteries; ToF, tetralogy of Fallot; VSD, ventricular septal defect. 
Figure 2. VWS and qualitative score results for both the pre-contrast (A) and post-contrast 
sequences (B). 
Figure 3. Coronary arteries qualitative score distribution for sequence A and B. 
Figure 4. VWS and qualitative score results for both the pre-contrast (A) and post-contrast 
sequences (B), for of each coronary artery. 
Figure 5. Scatter plots showing no correlation between VWS and potential image detrimental 
factors such as age, BSA and  HR. 
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TABLES 
 
Table 1. Image quality grading system 
1 - Poor-quality 
Non-diagnostic 
2 - Marked blurring 
3 – Moderate blurring 
Diagnostic 4 – Minimal blurring 
5 - Sharply defined borders 
 
 
 
 
 
Table 2.  Patient characteristics 
Age (years) 6  ± 2.8 ]2;12] 
Gender 29 male (73%); 11 female (27%) 
BSA (Kg/m
2
) 
 
0.75 ± 0.31 
Clinical 
Indication 
Aortic coarctation/interrupted arch 7 
Tetralogy of Fallot/Pulmonary atresia 6 
ASD/VSD 3 
HLHS 3 
Pulmonary atresia 3 
TGA 2 
PAPVR 2 
Ebstein’s anomaly 1 
Common arterial trunk 1 
Coronary fistula 1 
Marfan’s syndrome 1 
Complex CHD 10 
 N=40 
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Table 3. CMRA parameters 
Sequence A 
(pre) 
Sequence B 
(post) 
p 
value 
95% Confidence 
Interval of the 
Difference 
Acquisition duration (minutes) 5.3 ± 1.8 5.2  ± 1.5 0.532 [-0.218, 0.415] 
Heart rate (bpm) 78 ± 14.7 [56-109] 78 ± 14.5 [54-114] 0.443 [-0.644, 1.444] 
Mean vessel length (cm) 5.2 ± 1.8 6.4 ± 2.0 <0.001 [- 1.670, - 0.772] 
Average vessel diameter (mm) 2.2 ± 0.2 2.2 ± 0.2 0.922 [- 0.055, 0.061] 
Signal to noise ratio 12.6 ± 4.4 31.1 ± 7.4 <0.001 [-188.478, -128.625] 
Contrast to noise ratio 9.0 ± 1.8 13.5 ± 3.7 <0.001 [- 7.244,  -4.306] 
Coronary arteries vessel sharpness 0.53 ± 0.07 0.56 ± 0.07 0.001 [- 0.045, - 0.012] 
Table 4. Coronary arteries anomalies identified 
Main clinical diagnosis Coronary anomaly 
Single outlet right ventricle Single coronary 
Transposition of the great arteries Anomalous origin of the RCA from the LAD 
Tetralogy of Fallot Dual LAD supply 
Tricuspid stenosis Single coronary 
Coronary-cameral fistula RCA fistula to left atrium 
ACCEPTED MANUSCRIPT
AC
CE
PT
ED
 M
AN
US
CR
IP
T
 29 
Table 5. Coronary arteries average qualitative score and non-diagnostic segments 
Coronaries Segments 
Sequence A Sequence B p value 
Score Non-diagnostic Score Non-diagnostic Score Non-diagnostic 
All 
Coronaries 
All  
Segments 
3.8 ± 0.59 42 (13.1%) 4.1 ± 0.53 33 (10.3%) <0.001 0.002 
LAD 
All  3.9 ± 0.98 9 (7.5%) 4.2 ± 0.96 8 (6.7%) 0.009 0.566 
Proximal 4.5 ± 0.72 0 4.8 ± 0.45 0 0.002 >0.999 
Mid 4.2 ± 0.83 2 4.2 ± 0.79 1 0.670 0.323 
Distal 3.2 ± 0.91 7 3.6 ± 1.08 7 0.01 >0.999 
LCx 
All LCx 3.6 ± 1.11 20 (25%) 4.0 ± 1.11 14 (17.5%) 0.005 0.019 
Proximal 4.2 ± 0.87 3 4.7 ± 0.48 0 0.002 0.083 
Mid and distal 3.3 ± 1.10 17 3.7 ± 1.19 14 0.002 0.002 
RCA 
All RCA 3.9 ± 1.03 13 (10.8%) 4.1 ± 1.09 11 (9.2%) 0.037 0.033 
Proximal 4.5 ± 0.60 0 4.7 ± 0.55 0 0.088 0.323 
Mid 3.6 ± 1.02 3 3.8 ± 1.14 3 0.042 0.160 
Distal 3.2 ± 1.06 10 3.4 ± 1.15 8 0.192 0.183 
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SUPPLEMENTARY MATERIAL 
 
 
Figure 1. Soap-Bubble user interface. A reformatted CMRA image is generated (viewport 4) after 
manually tracking in three orthogonal views (viewports 1 to 3) the coronary artery path (yellow 
crosses). The vessel length is measured along the validated user-specified points in the reformatted 
coronary artery as described by Etienne A et al (2002) (20). 
 
Figure 2. Examples of consensual image quality scores given by the two independent readers to each 
coronary segments of the LAD (panel A), LCx (panel B) and RCA (panel C).  
 
Figure 3. Bland-Altman plots showing the intra-observer agreement for the qualitative 
coronary assessment of sequence A and B. The mean bias and 95% limits of agreement 
(±1.96 SD) are presented. 
 
Figure 4. Bland-Altman plots depicting the inter-observer agreement for the coronary scoring 
system used for qualitative assessment of both sequence A and B. The mean difference and 
95% limits of agreement (±1.96 SD) are presented. 
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